Adams May Cough Up Humibid As Product Confusion Congests Sales
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics is considering whether to stop offering its Humibid 1,200 mg guaifenesin product, which it markets voluntarily behind the counter, as it launches an over-the-counter version of the same product under the name Maximum Strength Mucinex